Bone marrow necrosis secondary to metastatic adenocarcinoma revealed by 18F-FDG PET/CT: A clinical case report

Medicine (Baltimore). 2017 Dec;96(49):e9067. doi: 10.1097/MD.0000000000009067.

Abstract

Rationale: Bone marrow necrosis (BMN) is a rare malignancy-associated hematologic disorder characterized by necrosis of myeloid and stromal marrow elements with preservation of cortical bone.

Patient concerns: A 43-year-old female complaining of dizziness and vaginal bleeding for more than 2 months was presented to our department.

Diagnosis: Due to the laboratory test results, radiographic findings, especially F-fluoro-2-deoxy-D-glucose (F-FDG) positron emission tomography/computed tomography (PET/CT) which revealed that bone marrow was characterized by diffuse F-FDG uptake with extensive central photopenia, and pathologic results, she was diagnosed with metastatic adenocarcinoma accompanied with BMN. And the cancer most likely originated from reproductive system or breast.

Interventions: There was no effective interventions for her before knowing the accurate origin of adenocarcinoma.

Outcomes: Two weeks later, unfortunately, she died.

Lessons: F-FDG PET/CT is a useful diagnostic modality in patients with BMN. Malignant tumor should always be considered in patients with extensive BMN, even in young people.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / diagnostic imaging*
  • Adenocarcinoma / pathology*
  • Adult
  • Bone Marrow Neoplasms / diagnostic imaging*
  • Bone Marrow Neoplasms / pathology*
  • Fatal Outcome
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Necrosis
  • Neoplasms, Unknown Primary / diagnostic imaging*
  • Neoplasms, Unknown Primary / pathology*
  • Positron Emission Tomography Computed Tomography*
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18